Ping Hu

Ping Hu is an accomplished clinical pharmacology expert with extensive experience in oncology drug development, currently serving as Associate Director at EMD Serono, Inc. since July 2019, where responsibilities include leading the Clinical Pharmacology Expert Team (CPET) and driving initiatives for late and early-phase compounds. Previously, from October 2015 to July 2019, Ping Hu worked at the FDA as a Clinical Pharmacologist and ORISE Fellow, focusing on pharmacometric reviews and systematic studies that enhanced drug delivery mechanisms and optimized dosing regimens for oncologic therapies. Ping Hu holds a Ph.D. in Biological Chemistry from The Johns Hopkins University School of Medicine, a Master of Health Science in Biostatistics from the Johns Hopkins Bloomberg School of Public Health, and a Bachelor of Pharmacy in Pharmacology from Fudan University.